Martek Biosciences Corp: Premium Company Profile
Scope
Report Highlights
Reasons to Purchase
Table of Contents
- Overview - page 1
- Catalyst - page 1
- Summary - page 1
- Table of Contents - page 3
- Table of figures - page 4
- Table of tables - page 5
- Company Structure - page 6
- Company Overview and Key Facts - page 6
- Business Description - page 7
- Landmark Products & Services - page 8
- Life'sDHA - page 8
- Landmark Products & Services - page 8
- History - page 9
- M&A History - page 11
- OmegaTech - page 11
- FermPro Manufacturing - page 11
- M&A History - page 11
- Locations and Subsidiaries - page 12
- Company Financials - page 13
- Stock Market Performance - page 13
- P&L - page 14
- Balance Sheet - page 17
- Cash Flow - page 17
- Business Segment Performance - page 18
- Products & Services - page 20
- Marketed Products - page 20
- Life'sDHA - page 20
- DHASCO - page 20
- Neuromins - page 20
- ARASCO - page 20
- Marketed Products - page 20
- Competitors and Strategic Business Relationships - page 21
- Top Competitors - page 21
- Key Suppliers - page 22
- Key Clients - page 22
- Shareholding Structure - page 23
- Strategy - page 24
- Company View - page 24
- Corporate Strategy - page 27
- SWOT Analysis - page 29
- Overview - page 29
- Strengths - page 30
- life'sDHA - page 30
- Strong production capabilities and sales network - page 30
- Weaknesses - page 32
- Reliance on limited customers - page 32
- Opportunities - page 33
- International expansion - page 33
- Regulatory approvals - page 33
- Threats - page 34
- Litigations - page 34
- Pricing pressures - page 34
- Value Chain Analysis - page 35
- Overview - page 35
- Discovery and Product Development - page 36
- Manufacturing - page 36
- Sales - page 36
- Key Employees - page 37
- List of Key Employees - page 37
- Key Employee Biographies - page 38
- Steve Dubin - page 38
- James R Beery - page 38
- Robert J Flanagan - page 39
- Polly B Kawalek - page 39
- Jerome C Keller - page 39
- Douglas J MacMaster - page 40
- Eugene H Rotberg - page 40
- Harry D'Andrea - page 40
- David Abramson - page 41
- Peter L Buzy - page 41
- Peter A Nitze - page 42
- David M Feitel - page 42
- Barney Easterling - page 42
- Tim Fealey - page 43
- Financial and Operational Overview - page 44
- Financial and Operational Overview - page 44
- Appendix - page 46
- Ask the analyst - page 46
- Datamonitor consulting - page 46
- Disclaimer - page 46
- List of Tables
- Table 1: Martek Biosciences - Key Facts - page 6
- Table 2: Martek Biosciences - Other Locations and Subsidiaries - page 12
- Table 3: Martek Biosciences - Year-End Share Price and Market Capitalization, 2002-2006 ($) - page 13
- Table 4: Martek Biosciences - Key Events Impacting Share Price Performance - page 13
- Table 5: Martek Biosciences - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) - page 14
- Table 6: Martek Biosciences - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) - page 16
- Table 7: Martek Biosciences - Balance Sheet, 2002-2006 ($ Mn) - page 17
- Table 8: Martek Biosciences - Cash Flow, 2002-2006 ($ Mn) - page 17
- Table 9: Martek Biosciences - Revenue Breakdown, 2002-2006 ($ Mn) - page 18
- Table 10: Martek Biosciences - Marketed Products - page 20
- Table 11: Martek Biosciences - Top Competitors - page 21
- Table 12: Martek Biosciences - Key Clients - page 22
- Table 13: Martek Biosciences - Key Shareholders - page 23
- Table 14: Martek Biosciences - SWOT Analysis Summary - page 29
- Table 15: Martek Biosciences - Value Chain Analysis - page 35
- Table 16: Martek Biosciences - Key Employees - page 37
- Table 17: Martek Biosciences - Financial and Operational Overview - page 44
- List of Figures
- Figure 1: Martek Biosciences - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) - page 15
- Figure 2: Martek Biosciences - Key Strategic Revenues, 2002-2006 ($ Mn) - page 19
Other users found this report page using the following search terms: Martek Biosciences martek biosciences dha neuromins corporation bioscience uk cardiovascular swot market
If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.
Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.